I am the senior director of R&D Asia-Pacific Hub, LEO Pharma.
I started my career as an academic scientist and performed my research at RIKEN, Dana-Farber Cancer Institute/Harvard Medical School, and Mie University Graduate School of Medicine. Throughout my academic career, I have been awarded fellowships from Human Frontier Science Program, RIKEN, Japan Society for the Promotion of Science and Japan Science and Technology Agency.
To foster a smooth transition of scientific excellence into real-life innovation, I pivoted my career into the pharmaceutical industry. In 2014 I joined Bayer, a Germany-based life science company, and served as Alliance Manager / Senior Scientist at Open Innovation Center Japan. I contributed to strengthening open innovation through partnerships with academia, startups and other major corporates. Among various areas of his responsibilities, I developed my specialty in cancer research and precision medicine.
In 2019 I moved to LEO Pharma and founded an external scouting function that spearheads innovation in medical dermatology. I also serve as a Program Champion for Venture Cafe Tokyo’s Life Science Cluster Program, a Bio-Business Adviser for Sapporo-city, and a mentor for Block Buster Tokyo program.
Invited by: つぼい
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
March 23, 2024 | 84 | 0 | 0.0% |
June 17, 2023 | 84 | 0 | 0.0% |
March 15, 2022 | 84 | -1 | -1.2% |
January 17, 2022 | 85 | +1 | +1.2% |
November 01, 2021 | 84 | +2 | +2.5% |